ERBB2 and breast cancer: Investigating the reasons for ethnic inequalities in breast cancer survival in New Zealand revealed that inequalities persisted even after adjusting for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (ER/PR/HER2) subtype variables.